This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
broker-rating: Archive
Builders FirstSource (BLDR) Is Considered a Good Investment by Brokers: Is That True?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in Builders FirstSource (BLDR). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
BLDRNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is Twilio (TWLO) a Buy as Wall Street Analysts Look Optimistic?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in Twilio (TWLO). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
TWLONegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Brokers Suggest Investing in Palo Alto (PANW): Read This Before Placing a Bet
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Palo Alto (PANW) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
PANWNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is It Worth Investing in Ardmore Shipping (ASC) Based on Wall Street's Bullish Views?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Ardmore Shipping (ASC) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
ASCPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Analysts Think AppFolio (APPF) Is a Good Investment: Is It?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), AppFolio (APPF) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
APPFNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is It Worth Investing in Intuitive Surgical (ISRG) Based on Wall Street's Bullish Views?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Intuitive Surgical (ISRG) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
ISRGNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is It Worth Investing in Agnico (AEM) Based on Wall Street's Bullish Views?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Agnico (AEM) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
AEMNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is Bit Digital (BTBT) a Buy as Wall Street Analysts Look Optimistic?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Bit Digital (BTBT) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
BTBTNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Analysts Think Marvell (MRVL) Is a Good Investment: Is It?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Marvell (MRVL) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
MRVLNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is It Worth Investing in e.l.f. Beauty (ELF) Based on Wall Street's Bullish Views?
by Zacks Equity Research
The average brokerage recommendation (ABR) for e.l.f. Beauty (ELF) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
ELFNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Celestica (CLS) Is Considered a Good Investment by Brokers: Is That True?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Celestica (CLS) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
CLSPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Brokers Suggest Investing in Celsius (CELH): Read This Before Placing a Bet
by Zacks Equity Research
The average brokerage recommendation (ABR) for Celsius (CELH) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
CELHNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Bulls Look Optimistic About Veeva (VEEV): Should You Buy?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Veeva (VEEV) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
VEEVNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is It Worth Investing in Tutor Perini (TPC) Based on Wall Street's Bullish Views?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Tutor Perini (TPC) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
TPCPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Brokers Suggest Investing in Snowflake (SNOW): Read This Before Placing a Bet
by Zacks Equity Research
The average brokerage recommendation (ABR) for Snowflake (SNOW) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
SNOWNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is It Worth Investing in Newmont (NEM) Based on Wall Street's Bullish Views?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Newmont (NEM) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
NEMPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is It Worth Investing in Nvidia (NVDA) Based on Wall Street's Bullish Views?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Nvidia (NVDA) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
NVDAPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is ASML (ASML) a Buy as Wall Street Analysts Look Optimistic?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), ASML (ASML) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
ASMLNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is It Worth Investing in Chevron (CVX) Based on Wall Street's Bullish Views?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Chevron (CVX) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
CVXPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Analysts See PulteGroup (PHM) as a Buy: Should You Invest?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in PulteGroup (PHM). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
PHMNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is It Worth Investing in Synopsys (SNPS) Based on Wall Street's Bullish Views?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Synopsys (SNPS) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
SNPSNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Bulls Look Optimistic About Enterprise Products (EPD): Should You Buy?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in Enterprise Products (EPD). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
EPDNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is It Worth Investing in The Trade Desk (TTD) Based on Wall Street's Bullish Views?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), The Trade Desk (TTD) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
TTDNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is It Worth Investing in TJX (TJX) Based on Wall Street's Bullish Views?
by Zacks Equity Research
The average brokerage recommendation (ABR) for TJX (TJX) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
TJXNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Adma Biologics (ADMA) Is Considered a Good Investment by Brokers: Is That True?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Adma Biologics (ADMA) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
ADMANegative Net Change
broker-rating earnings-estimates-revisions earnings-growth